Irinotecan and Capecitabine in Treating Patients With Solid Tumors
Status:
Completed
Trial end date:
2003-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase I trial to study the effectiveness of irinotecan and capecitabine in treating
patients who have solid tumors that have not responded to previous treatment.
Phase:
Phase 1
Details
Lead Sponsor:
Albert Einstein College of Medicine of Yeshiva University Montefiore Medical Center